Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1317

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 5
Chunk 1317
---
-    -    -   Expired   -    -    -   Total outstanding, December 31, 2023   52,737   $369.98    4.47   Total exercisable, December 31, 2023   52,737   $369.98    4.47  

F-22

During the year ended December 31, 2023, the
Company received aggregate cash proceeds of $1,131,771 upon the exercise of 525 Bridge Warrants, 1,000 Non-tradeable Warrants, and 1,550
Tradeable Warrants.

The following table presents a summary of the
activity for the Company’s equity-classified warrants during the year ended December 31, 2024:

     Number of Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life  (Years)   Total outstanding, December 31, 2023   52,737   $369.98    4.47   Granted(1)   1,923,496    6.00    3.47   Exercised   (211,163)   0.05    Indefinite   Forfeited   -    -    -   Expired   -    -    -   Total outstanding, December 31, 2024(1)   1,765,070   $17.59    3.26   Total exercisable, December 31, 2024(1)   1,765,070   $17.59    3.26  

(1)Weighted average remaining contractual life calculations exclude (i) 16,652 Pre-Funded Warrants issued January 2024 that do not have a contractual expiration date, for which 0 remain outstanding at December 31, 2024 and (ii) 579,711 Pre-Funded Warrants granted September 2024 that do not have a contractual expiration date, for which 385,200 remain outstanding and are exercisable at December 31, 2024.

During the year ended December 31, 2024, the
Company received aggregate cash proceeds of $10,963 upon the exercise of